Drug Trial Radar · NCT07725575
Efficacy of Intrathecal Administration of Budesonide to Prevent Bronchopulmonary Dysplasia
Last checked: Nov 19, 2026Latest source record: Jul 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
86
Actual
Start
Nov 1, 2024
Primary completion
Apr 24, 2025
Study completion Jun 1, 2025
Sponsor
- Lead sponsor
- Universitas IndonesiaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 24, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, up to 48 hours
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn if budesonide works to prevent bronchopulmonary dysplasia in newborn less than 32 weeks gestational age or birth weight less than 1500 g with respiratory distress syndrome who needs surfactants. Does budesonide lower the incidence of bronchopulmonary dysplasia? What medical problems do participants have after given budesonide? Researchers will compare intratracheal budesonide and surfactant to intratracheal surfactant only to see if budesonide works to prevent bronchopumonary dysplasia. Participants will: Given intratracheal budesonide and surfactant and followed up until 36 weeks of post menstrual age to determine whether they have bronchopulmonary dysplasia or not
Conditions
- Bronchopulmonary Dysplasia (BPD)
Interventions
ExperimentalDrug
budesonide 25 mg/kg + beractant 100 mg/kg administered intratracheal
Primary outcomes
What the sponsor says the trial is designed to measure.
- Bronchopulmonary dysplasiaTime frame: subject collection: 8 months, data processing 1 month, publication 1 month
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Cipto Mangunkusumo Hospital
Jakarta, DKI Jakarta, Indonesia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.